Novartis’ Beovu recommended by NICE
Patients set to benefit from new treatment for sight-threatening eye condition Thousands of…
Patients set to benefit from new treatment for sight-threatening eye condition Thousands of…
Predicting which women are likely to develop pre-eclampsia will help clinicians to decide…
First carbon minimal pMDI is on track with the joint goal of benefitting…
Funding will develop inhaled therapies using ICOone Nasal in preparation for the next…
Voxelotor is the first medicine in Britain to directly inhibit sickle haemoglobin polymerisation…
Therapy effectively treats adults with active lupus nephritis in Europe Aurinia has announced…
Imvanex to include protection from monkeypox and diseases caused by vaccinia virus Bavarian…
Rhythm Pharmaceuticals has announced that the National Institute for Health and Care Excellence…
Vicebio has announced its aim to accelerate the development of novel vaccines against…
Difficult choices loom regarding which areas of patient care to cut back NHS…